Table 1. Marker evaluation pipeline: cases and controls.

Patient Class	Filtering Set	Mini-Triage Set	Triage Set	Overlapa
Ovarian Cancer Cases	50	35	71	17
Healthy Controlsb	9	12	58	12
Surgical Benignsc	0	16	53	16
Surgical Normalsd	0	8	32	8
Total	59	71	214

^a)Overlapping specimens in the Mini-Triage and Triage sets

^b)Healthy Controls: women enrolled in prospective screening trials who remained free of ovarian cancer for at least two years after serum collection.

^c)Surgical Benigns: women with surgically confirmed benign ovarian pathology.

^d)Surgical Normals: women that underwent surgery but no ovarian pathology was identified.